about
Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humansA canine model of experimental infection with Leishmania (L.) mexicanaIL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease.T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccineInterleukin-10 from T cells, but not macrophages and granulocytes, is required for chronic disease in Leishmania mexicana infection.T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?Antibody-Fc receptor interactions in protection against intracellular pathogens.The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.Comment on "Regulation of immunity during visceral Leishmania infection" and further discussions about the role of antibodies in infections with Leishmania.An antigenic domain of the Leishmania amazonensis nucleoside triphosphate diphosphohydrolase (NTPDase 1) is associated with disease progression in susceptible infected mice.Evaluation of a novel lentiviral vaccine expressing KMP11-HASPB fusion protein against Leishmania infantum in BALB/c mice.Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection
P2860
Q28487831-F2A30AC2-CEAA-4EBE-B584-AB7F3C375827Q34067596-0855ADF0-67A6-4F77-A6BC-AC061402DE9AQ34145683-7611CA23-B79E-4991-B2B5-87D54D7DFBE0Q34795494-6265E50E-BF58-4C38-8DB3-AF791E630389Q35187588-1ED9CB5F-24E4-4EAE-9421-B93BBC164F2AQ35928348-18AB7AD7-0D79-4692-B7F3-20B6E63E3C1EQ37853942-CAB5481E-EC1F-4ED6-83AD-235A4B31BDC8Q39395136-5E954107-7C19-4471-9902-A0A48C6A42A0Q41622831-2714AFBD-C95F-4B36-8522-11F1E6DE9902Q42429227-333E6B2D-1A64-4B93-A988-C68943C393F1Q46310093-6366FADF-1DC8-4D71-80F9-B3F79491D4E5Q47853580-BEBFBBDC-74EB-4865-A15C-FC9D242F942CQ58853990-AE7A4F6C-D237-48AB-A5AC-6954FD9C986D
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
IgG1 is pathogenic in Leishmania mexicana infection
@ast
IgG1 is pathogenic in Leishmania mexicana infection
@en
IgG1 is pathogenic in Leishmania mexicana infection
@nl
type
label
IgG1 is pathogenic in Leishmania mexicana infection
@ast
IgG1 is pathogenic in Leishmania mexicana infection
@en
IgG1 is pathogenic in Leishmania mexicana infection
@nl
prefLabel
IgG1 is pathogenic in Leishmania mexicana infection
@ast
IgG1 is pathogenic in Leishmania mexicana infection
@en
IgG1 is pathogenic in Leishmania mexicana infection
@nl
P2093
P2860
P356
P1476
IgG1 is pathogenic in Leishmania mexicana infection
@en
P2093
Bolaji N Thomas
Laurence U Buxbaum
Niansheng Chu
Supriya R Patel
P2860
P304
P356
10.4049/JIMMUNOL.1002484
P407
P577
2010-10-29T00:00:00Z